We are aware that a message is circulating on local social media suggesting that Tirzepatide (Mounjaro) will be available for weight loss prescriptions from GPs starting 23rd June. As a result, we have received a high volume of enquiries.
Please note that while the guidance refers to ‘primary care’, this does not mean individual GP practices. We have been explicitly advised not to prescribe this medication.
Find out more about Mounjaro (Tirzepatide) access in Cheshire and Merseyside on the ICB website.
People in England over the age of 18 living with obesity and weight-related health
issues, will be able to access the weight loss drug Tirzepatide (Mounjaro®).
Tirzepatide is currently prescribed for the treatment of type 2 diabetes mellitus but
will now also be available for weight loss purposes
For more information, please the see the Tirzepatide (Mounjaro®) FAQs (PDF).